ABOUT THE PRODUCT
JadiCell™ is a patented, allogeneic umbilical cord-derived mesenchymal stem cell therapy designed to reduce mortality and improve outcomes in patients with Acute Respiratory Distress Syndrome (ARDS), COPD, and other severe lung diseases. It’s a ‘next-generation’ therapeutic with the potential to cross the blood-brain barrier and modulate neuroinflammation.
Information is owner-confirmed
Last updated 2 weeks ago
Price range